Hamburg

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Glioblastoma1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company3 trials

Running trials

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

  NCT02152631· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

  NCT02675231· Phase 2· Eli Lilly and Company· Source

• Completed

  A Study in Recurrent Glioblastoma (GB)

  NCT01582269· Phase 2· Eli Lilly and Company· Source